Aspen Aerogels (NYSE:ASPN) Price Target Lowered to $22.00 at B. Riley

Aspen Aerogels (NYSE:ASPN) had its price objective lowered by B. Riley from $35.00 to $22.00 in a research note released on Wednesday,Benzinga reports. The firm currently has a buy rating on the construction company’s stock.

ASPN has been the topic of a number of other research reports. Piper Sandler lowered their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Roth Mkm dropped their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Craig Hallum dropped their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Finally, StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.44.

Aspen Aerogels Trading Down 2.6 %

ASPN stock opened at $8.32 on Wednesday. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15. The stock has a market cap of $682.38 million, a price-to-earnings ratio of 51.98 and a beta of 2.14. The company has a fifty day moving average price of $11.85 and a two-hundred day moving average price of $18.22. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Equities analysts anticipate that Aspen Aerogels will post 0.46 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC increased its stake in shares of Aspen Aerogels by 415.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 238,884 shares of the construction company’s stock valued at $6,615,000 after purchasing an additional 192,520 shares during the last quarter. Dakota Wealth Management acquired a new position in Aspen Aerogels during the third quarter worth about $986,000. Rice Hall James & Associates LLC lifted its holdings in shares of Aspen Aerogels by 19.9% in the third quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock worth $14,817,000 after acquiring an additional 88,711 shares during the last quarter. Pursue Wealth Partners LLC acquired a new stake in shares of Aspen Aerogels in the 3rd quarter valued at approximately $222,000. Finally, Bridgewater Advisors Inc. grew its holdings in shares of Aspen Aerogels by 37.8% during the 3rd quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company’s stock valued at $2,142,000 after purchasing an additional 21,218 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.